Identifying suicidal symptoms in prostate cancer survivors using brief self-report - Abstract

PURPOSE: Prostate cancer (PC) survivors are at elevated risk for completed suicide even many years post-treatment.

Despite this risk, practical and efficient methods for assessing these symptoms have not been established. We sought to determine if suicidal symptoms could be effectively and efficiently identified in a cohort of PC survivors, and whether these men were receptive to emotional health interventions.

METHODS: Six hundred fifty-six PC survivors, an average of 5 years post-diagnosis, completed eight self-report items about suicidal symptoms and behavior in the past 7 days, and 12 months, as well as medical utilization and interest in emotional health support.

RESULTS: Between 3.6 and 17.9 % of PC survivors endorsed a single suicidal ideation item, and denied all other ideation. All survivors who endorsed serious suicidal ideation/behavior also endorsed either passive or active ideation. 58.3 % of survivors denied any suicidal symptoms within the past week, but endorsed it within the past year. Most survivors had medical provider contact within the past year and were open to receiving information about emotional health interventions.

CONCLUSIONS: Suicidal ideation in PC survivors cannot be accurately evaluated using only a one-item screen, or by inquiring within a single time frame.

IMPLICATIONS FOR CANCER SURVIVORS: In both research and clinical settings, the evaluation for suicidal ideation in PC survivors should utilize multiple questions, across several time periods. It is possible to skip queries about serious ideation/behavior if passive or active ideation is denied. Once identified, medical providers should refer these men to psychosocial providers who can offer emotional support.

Written by:
Zhou ES, Hu JC, Kantoff PW, Recklitis CJ.   Are you the author?
Dana-Farber Cancer Institute, 450 Brookline Avenue, Boston, MA, 02215, USA.

Reference: J Cancer Surviv. 2014 Aug 19. Epub ahead of print.
doi: 10.1007/s11764-014-0385-z

PubMed Abstract
PMID: 25135206 Prostate Cancer Section


Newsletter subscription

Free Daily and Weekly newsletters offered by content of interest

The fields of GU Oncology and Urology are rapidly advancing. Sign up today for articles, videos, conference highlights and abstracts from peer-review publications by disease and condition delivered to your inbox and read on the go.